Artigos com autorizações de acesso público - Maurizio ZazziSaiba mais
Não disponíveis em nenhum local: 9
Evaluation of sofosbuvir activity and resistance profile against West Nile virus in vitro
F Dragoni, A Boccuto, F Picarazzi, A Giannini, F Giammarino, F Saladini, ...
Antiviral research 175, 104708, 2020
Autorizações: Government of Italy
Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens?
VC Di Maio, V Cento, M Aragri, S Paolucci, T Pollicino, N Coppola, ...
Journal of hepatology 68 (3), 597-600, 2018
Autorizações: Government of Italy
Computer-aided optimization of combined anti-retroviral therapy for HIV: new drugs, new drug targets and drug resistance
M Zazzi, A Cozzi-Lepri, MCF Prosperi
Current HIV research 14 (2), 101-109, 2016
Autorizações: UK Medical Research Council, European Commission
Resistance analysis and treatment outcomes in hepatitis C virus genotype 3‐infected patients within the Italian network VIRONET‐C
VC Di Maio, S Barbaliscia, E Teti, G Fiorentino, M Milana, S Paolucci, ...
Liver International 41 (8), 1802-1814, 2021
Autorizações: Government of Italy
Predicting human-immunodeficiency virus rebound after therapy initiation/switch using genetic, laboratory, and clinical data
M Prosperi, A Pironti, F Incardona, G Tradigo, M Zazzi
Proceedings of the 7th ACM International Conference on Bioinformatics …, 2016
Autorizações: European Commission
Synthesis and biological investigation of peptidomimetic SARS‐CoV‐2 main protease inhibitors bearing quinoline‐based heterocycles at P3
S Rossi, G Deidda, L Fiaschi, R Ibba, M Pieroni, M Dichiara, G Carullo, ...
Archiv der Pharmazie 358 (1), e2400812, 2025
Autorizações: European Commission
In vitro susceptibility of HIV-1 CRF02_AG to temsavir, the active compound of the attachment inhibitor fostemsavir
F Saladini, A Giannini, F Giammarino, A Boccuto, F Dragoni, I Vicenti, ...
Journal of Antimicrobial Chemotherapy 76 (12), 3310-3312, 2021
Autorizações: National Natural Science Foundation of China, European Commission
Integrase strand transfer inhibitor-based regimen is related with a limited HIV-1 V3 loop evolution in clinical practice
C Alteri, R Scutari, A Bertoli, D Armenia, C Gori, G Fabbri, CM Mastroianni, ...
Virus Genes 55, 290-297, 2019
Autorizações: Government of Italy
Interpretation of genotypic resistance to predict darunavir/ritonavir failure in antiretroviral experienced patients
G Sterrantino, M Zaccarelli, M Trotta, A De Luca, V Borghi, P Meraviglia, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 59 (2), 170-172, 2012
Autorizações: US National Institutes of Health
Disponíveis em algum local: 91
Beyond sparsity: Tree regularization of deep models for interpretability
M Wu, M Hughes, S Parbhoo, M Zazzi, V Roth, F Doshi-Velez
Proceedings of the AAAI conference on artificial intelligence 32 (1), 2018
Autorizações: US National Science Foundation, Swiss National Science Foundation
European guidelines on the clinical management of HIV-1 tropism testing
LPR Vandekerckhove, AMJ Wensing, R Kaiser, F Brun-Vézinet, B Clotet, ...
The Lancet infectious diseases 11 (5), 394-407, 2011
Autorizações: Research Foundation (Flanders)
Transmission of HIV drug resistance and the predicted effect on current first-line regimens in Europe
LM Hofstra, N Sauvageot, J Albert, I Alexiev, F Garcia, D Struck, ...
Clinical infectious diseases 62 (5), 655-663, 2016
Autorizações: Research Foundation (Flanders), Swedish Research Council
Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach
D Paraskevis, O Pybus, G Magiorkinis, A Hatzakis, AMJ Wensing, ...
Retrovirology 6, 1-11, 2009
Autorizações: Research Foundation (Flanders)
A novel methodology for large-scale phylogeny partition
MCF Prosperi, M Ciccozzi, I Fanti, F Saladini, M Pecorari, V Borghi, ...
Nature communications 2 (1), 321, 2011
Autorizações: US National Institutes of Health
SARS-CoV-2 RNA-dependent RNA polymerase as a therapeutic target for COVID-19
I Vicenti, M Zazzi, F Saladini
Expert Opinion on Therapeutic Patents 31 (4), 325-337, 2021
Autorizações: Government of Italy
Human DDX3 protein is a valuable target to develop broad spectrum antiviral agents
A Brai, R Fazi, C Tintori, C Zamperini, F Bugli, M Sanguinetti, E Stigliano, ...
Proceedings of the National Academy of Sciences 113 (19), 5388-5393, 2016
Autorizações: Government of Spain, Government of Italy
Declining prevalence of HIV-1 drug resistance in antiretroviral treatment-exposed individuals in Western Europe
A De Luca, D Dunn, M Zazzi, R Camacho, C Torti, I Fanti, R Kaiser, ...
The Journal of infectious diseases 207 (8), 1216-1220, 2013
Autorizações: Research Foundation (Flanders), UK Medical Research Council
New findings in HCV genotype distribution in selected West European, Russian and Israeli regions
V Kartashev, M Döring, L Nieto, E Coletta, R Kaiser, S Sierra, A Guerrero, ...
Journal of Clinical Virology 81, 82-89, 2016
Autorizações: Research Foundation (Flanders)
Combining kernel and model based learning for HIV therapy selection
S Parbhoo, J Bogojeska, M Zazzi, V Roth, F Doshi-Velez
AMIA Summits on Translational Science Proceedings 2017, 239, 2017
Autorizações: Swiss National Science Foundation
Comparison of HIV-1 genotypic resistance test interpretation systems in predicting virological outcomes over time
D Frentz, CAB Boucher, M Assel, A De Luca, M Fabbiani, F Incardona, ...
PloS one 5 (7), e11505, 2010
Autorizações: Research Foundation (Flanders)
As informações de publicação e financiamento são determinadas automaticamente por um programa informático.